Zimmer Partners, LP Replimune Group, Inc. Transaction History
Zimmer Partners, LP
- $4.52 Billion
- Q1 2025
Shares
2 transactions
Others Institutions Holding REPL
# of Institutions
171Shares Held
76.6MCall Options Held
69.4KPut Options Held
216K-
Baker Bros. Advisors LP New York, NY11MShares$79.9 Million1.28% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD10.9MShares$78.5 Million0.01% of portfolio
-
Redmile Group, LLC San Francisco, CA4.9MShares$35.4 Million5.02% of portfolio
-
Black Rock Inc. New York, NY4.71MShares$34.1 Million0.0% of portfolio
-
Fcpm Iii Services B.V. Naarden, P73.91MShares$28.3 Million9.21% of portfolio
About Replimune Group, Inc.
- Ticker REPL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 49,306,700
- Market Cap $356M
- Description
- Replimune Group, Inc., a biotechnology company, develops oncolytic immuno-gene therapies to treat cancer. It uses its proprietary Immunotherapy platform to design and develop product candidates that are intended to activate the immune system against cancer. The company's lead product candidate is RP1, a selectively replicating version of herpes ...